Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FEMMK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,822
Award facts
- Contract value 100% obligated
- $16,822.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,822.18 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on November 3, 2025, represents one of numerous orders placed under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the DLA. The contract requires no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will deliver pharmaceutical products and medical consumables to support Department of Defense medical supply chain operations, with performance scheduled for completion by November 4, 2025.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract designated SPE2DR within the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy established to provide comprehensive pharmaceutical support to military healthcare facilities worldwide. The parent IDC, valued at $499,999,999 with an ultimate completion date of December 31, 2036, authorizes DLA to issue delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables. DMS Pharmaceutical Group's established performance across numerous delivery orders spanning oncology treatments, immunosuppressants, emergency medications, and specialty pharmaceuticals demonstrates its critical role in supporting Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DU26FEMMK?
SPE2DU26FEMMK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DU26FEMMK worth?
The government has obligated $16,822 on SPE2DU26FEMMK.
Is contract SPE2DU26FEMMK an order under another contract?
Yes. SPE2DU26FEMMK is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMMK competed?
The extent of competition for SPE2DU26FEMMK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award